[Prognostic factors and treatment of 74 patients with dermatofibro-sarcoma protuberans]

Zhonghua Zhong Liu Za Zhi. 2005 Feb;27(2):122-5.
[Article in Chinese]

Abstract

Objective: To analyze treatment and prognostic factors of 74 patients with dermatofibro-sarcoma protuberans (DFSP).

Methods: From August 1990 to November 1999, 74 patients with DFSP confirmed pathologically were treated. There were 52 males and 22 females with a median age of 37 years (range 4 to 80 years) on diagnosis. Seventeen patients were treated by extensive excision and 2 by limited excision. Fifty-two patients had surgical resection alone (S), and 22 postoperative radiotherapy (S + R) of 50-70 Gy. The multivariate parameters were analyzed using Cox model. Kaplan-Meier and Log-Rank test were used to evaluate the results of the recurrence-free survival.

Results: The rate of recurrence was 28.4% for all patients. The 5-year recurrence-free survival rate (RFSR) was 66.6% and the 10-year RFSR was 52.5%. The 5-year and 10-year in the S group were 58.4% and 41.2%, compared with 90.0% and 83.3% in the S + R group (P < 0.05). The 5-year and 10-year RFSR in the pathologically positive margin group were 57.5% and 41.4% respectively, compared with the 75.0% and 56.6% in the pathologically negative group (P < 0.05). Multivariate analysis suggested radiotherapy and negative pathological margins were favorable prognostic factors.

Conclusion: Post-operation radiotherapy and pathological margin are the independent prognostic factors.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Dermatofibrosarcoma / mortality
  • Dermatofibrosarcoma / radiotherapy
  • Dermatofibrosarcoma / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Postoperative Care
  • Prognosis
  • Proportional Hazards Models
  • Retrospective Studies
  • Skin Neoplasms / mortality
  • Skin Neoplasms / radiotherapy
  • Skin Neoplasms / surgery*